Gracell Biotechnologies Inc. (GRCL) Financials
GRCL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 259.1 million | 36.9 million |
| 2023-06-30 | 190.2 million | 33.3 million |
| 2023-03-31 | 241.4 million | 40.9 million |
| 2022-12-31 | 240.4 million | 40.7 million |
GRCL Free Cash Flow and Stock based compensation
No data available :(
GRCL Net Income
No data available :(
GRCL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 234.1 million | - | 1.7 million |
| 2023-06-30 | 164.0 million | - | 2.1 million |
| 2023-03-31 | 212.5 million | - | 2.7 million |
| 2022-12-31 | 211.6 million | - | 3.5 million |
GRCL Shares Outstanding
GRCL Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 12.3 million | 4.3 million | - |
| 2023-06-30 | - | 14.3 million | 5.2 million | - |
| 2023-03-31 | - | 16.5 million | 5.3 million | - |
| 2022-12-31 | - | 16.4 million | 5.3 million | - |
GRCL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | - |
| 2023-06-30 | - | - |
| 2023-03-31 | - | - |
| 2022-12-31 | - | - |
GRCL
Price: $10.25
52 week price:
Earnings Per Share: -0.96 USD
P/E Ratio: -10.59
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.0 million
Market Capitalization: 989.9 million